TR
EN
Smoking in Pregnancy: Can the first-trimester serum inflammatory markers predict adverse obstetric and neonatal outcomes?
Öz
Aim: To investigate obstetric complications in pregnant women who smoke and to evaluate whether first-trimester systemic inflammatory indices can predict adverse obstetric and neonatal outcomes
Materials and Method: This retrospective study included 43 pregnant women aged between 18 and 45 years who had been smoking since prior to conception, and 44 healthy pregnant women, conducted between 2024 and 2025. Participants' demographic characteristics, obstetric outcomes (birth weight, gestational age at delivery), and neonatal outcomes (APGAR scores, NICU admission) and obstetric complications were assessed. First-trimester neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII: NLR × platelet count), systemic inflammation response index (SIRI: NLR × monocyte count), aggregate index of systemic inflammation (AISI: NLR × platelet count × monocyte count), and platelet-to-lymphocyte ratio (PLR) were calculated. Receiver operating characteristic (ROC) curves were generated to evaluate the predictive value of these markers for adverse obstetric and neonatal outcomes.
Results: SII, SIRI, AISI, and NLR levels were significantly higher in the smoking group compared to controls. Pregnant women who smoked had higher rates of emergency cesarean section, adverse obstetric outcomes, and NICU admissions. ROC analysis showed that first-trimester inflammatory markers significantly predicted adverse outcomes when all participants were analyzed together; however, these markers did not demonstrate predictive value within the smoking group alone.
Conclusion: Adverse obstetric outcomes, increased NICU admissions, and elevated serum inflammatory markers were observed in pregnant women who smoked. However, these markers were found to be insufficient in predicting adverse outcomes.
Anahtar Kelimeler
Destekleyen Kurum
None
Etik Beyan
The study was approved by the Clinical Research Ethics Committee of Uşak University (Ethics No: 715-715-19, Date: 12.06.2025) and was conducted in accordance with the Declaration of Helsinki. Since the data were anonymised and collected retrospectively, a waiver of written informed consent was granted.
Teşekkür
The authors would like to express their gratitude to all healthcare professionals dedicated to the fight against smoking.
Kaynakça
- 1 World Health Organization (WHO). Accessed: 25 June 2025 Available from: https://www.who.int/publications/i/item/9789240112063 2 Banderali G, Martelli A, Landi M, Moretti F, Betti F, Radaelli G, et al. Short and long term health effects of parental tobacco smoking during pregnancy and lactation: a descriptive review. Transl Med. 2015;13:327.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Kadın Hastalıkları ve Doğum
Bölüm
Klinik Araştırma
Yayımlanma Tarihi
30 Eylül 2025
Gönderilme Tarihi
10 Temmuz 2025
Kabul Tarihi
29 Temmuz 2025
Yayımlandığı Sayı
Yıl 2025 Cilt: 22 Sayı: 3
APA
Akgün Aktaş, B., & Bilicen, E. (2025). Smoking in Pregnancy: Can the first-trimester serum inflammatory markers predict adverse obstetric and neonatal outcomes? Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, 22(3), 300-305. https://doi.org/10.38136/jgon.1739115
AMA
1.Akgün Aktaş B, Bilicen E. Smoking in Pregnancy: Can the first-trimester serum inflammatory markers predict adverse obstetric and neonatal outcomes? JGON. 2025;22(3):300-305. doi:10.38136/jgon.1739115
Chicago
Akgün Aktaş, Betül, ve Ezgi Bilicen. 2025. “Smoking in Pregnancy: Can the first-trimester serum inflammatory markers predict adverse obstetric and neonatal outcomes?”. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 22 (3): 300-305. https://doi.org/10.38136/jgon.1739115.
EndNote
Akgün Aktaş B, Bilicen E (01 Eylül 2025) Smoking in Pregnancy: Can the first-trimester serum inflammatory markers predict adverse obstetric and neonatal outcomes? Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 22 3 300–305.
IEEE
[1]B. Akgün Aktaş ve E. Bilicen, “Smoking in Pregnancy: Can the first-trimester serum inflammatory markers predict adverse obstetric and neonatal outcomes?”, JGON, c. 22, sy 3, ss. 300–305, Eyl. 2025, doi: 10.38136/jgon.1739115.
ISNAD
Akgün Aktaş, Betül - Bilicen, Ezgi. “Smoking in Pregnancy: Can the first-trimester serum inflammatory markers predict adverse obstetric and neonatal outcomes?”. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 22/3 (01 Eylül 2025): 300-305. https://doi.org/10.38136/jgon.1739115.
JAMA
1.Akgün Aktaş B, Bilicen E. Smoking in Pregnancy: Can the first-trimester serum inflammatory markers predict adverse obstetric and neonatal outcomes? JGON. 2025;22:300–305.
MLA
Akgün Aktaş, Betül, ve Ezgi Bilicen. “Smoking in Pregnancy: Can the first-trimester serum inflammatory markers predict adverse obstetric and neonatal outcomes?”. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, c. 22, sy 3, Eylül 2025, ss. 300-5, doi:10.38136/jgon.1739115.
Vancouver
1.Betül Akgün Aktaş, Ezgi Bilicen. Smoking in Pregnancy: Can the first-trimester serum inflammatory markers predict adverse obstetric and neonatal outcomes? JGON. 01 Eylül 2025;22(3):300-5. doi:10.38136/jgon.1739115